BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/9/2024 10:40:01 AM | Browse: 140 | Download: 896
 |
Received |
|
2024-09-07 03:21 |
|
Peer-Review Started |
|
2024-09-07 03:21 |
|
First Decision by Editorial Office Director |
|
2024-09-20 00:49 |
|
Return for Revision |
|
2024-09-20 00:49 |
|
Revised |
|
2024-09-28 20:11 |
|
Publication Fee Transferred |
|
2024-11-15 04:51 |
|
Second Decision by Editor |
|
2024-11-14 02:39 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-11-14 06:23 |
|
Articles in Press |
|
2024-11-14 06:23 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-11-28 07:49 |
|
Publish the Manuscript Online |
|
2024-12-09 10:40 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Loss-of-Function Mutations of MicroRNA-142-3p Promote ASH1L Expression to induce Immune Evasion and Hepatocellular Carcinoma Progression
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xing-Hui Yu, Yan Xie, Jian Yu, Kun-Ning Zhang, Zhou-Bo Guo, Di Wang, Zhao-Xian Li, Wei-Qi Zhang, Yu-Ying Tan, Li Zhang and Wen-Tao Jiang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Haihe Laboratory of Cell Ecosystem Innovation Fund |
No. 22HHXBJC00001 |
| Key Discipline Special Project of Tianjin Municipal Health Commission |
No. TJWJ2022XK016 |
|
| Corresponding Author |
Wen-Tao Jiang, MD, PhD, School of Medicine, Nankai University, No. 94 Weijin Road, Nankai District, Tianjin 300192, China. jiangwentao@nankai.edu.cn |
| Key Words |
Hepatocellular carcinoma; MicroRNA-142-3p; ASH1L; Immune evasion; Tumor immune microenvironment; Apoptosis |
| Core Tip |
This article mainly focuses on the new targets which may be beneficial to treat and predict HCC. We would like to shed light on the effects of MIR-142-3p and ASH1L on the HCC cell bioactivity and prognosis of HCC patients. Based on the experiments, loss function of microRNA-142-3p induces cancer progression and immune evasion through upregulation of ASH1L in hepatocellular carcinoma. Both microRNA-142-3p and ASH1L can feature as new biomarker for hepatocellular carcinoma in the future. In-depth comprehensive research is indispensable to completely clarity the ASH1L pathology and relevant molecular mechanisms in HCC progression. |
| Publish Date |
2024-12-09 10:40 |
| Citation |
Yu XH, Xie Y, Yu J, Zhang KN, Guo ZB, Wang D, Li ZX, Zhang WQ, Tan YY, Zhang L, Jiang WT. Loss-of-Function Mutations of MicroRNA-142-3p Promote ASH1L Expression to induce Immune Evasion and Hepatocellular Carcinoma Progression. World J Gastroenterol 2025; 31(1): 101198 |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i1/101198.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i1.101198 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
